ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,765 companies indexed · Last updated: today
DirectoryFinance & InsuranceHolding CompaniesGenevaNeurosterix Swiss Holdings AG
Neurosterix Swiss Holdings AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Neurosterix Swiss Holdings AG develops allosteric modulators to design targeted therapies for complex neuropsychiatric disorders. The company uses a proprietary discovery platform to identify selective positive and negative allosteric modulators and advances clinical and preclinical programs, including M4 PAM and mGlu7 NAM candidates for indications such as psychosis, mood, and anxiety disorders.

AI-generated
Offering

Products & services

Industry:Holding Companies
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

Neurosterix Swiss Holdings AG

✓ Offered5
Development of allosteric modulators
Development of novel allosteric modulators for neuropsychiatric diseases, focusing on psychotic, affective and anxiety disorders.
CNS therapy pipeline development
Pipeline with preclinical and clinical programs, including NTX-253, NTX-529 and NTX-819 for schizophrenia, psychosis, mood and anxiety disorders.
CNS research and drug discovery
Discovery engine with 80,000+ compounds, 200+ functional CNS assays, and screening campaigns to identify new drug candidates.
Translational science
Translating receptor pharmacology and preclinical data into clinical candidates, focusing on neuropsychiatric target structures and development readiness.
Clinical development
Planning and conducting clinical studies for novel neuropsychiatric therapeutics, including Phase 1 studies and further clinical development steps.
Trust & reputation

ranQ Trust Score of Neurosterix Swiss Holdings AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of October 2026

Neurosterix Swiss Holdings AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Neurosterix Swiss Holdings AG scores 66.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.39.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Neurosterix Swiss Holdings AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Neurosterix Swiss Holdings AG scores 22.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.22.94%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Neurosterix Swiss Holdings AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Neurosterix Swiss Holdings AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Neurosterix Swiss Holdings AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Neurosterix Swiss Holdings AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Neurosterix Swiss Holdings AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Chemin des Mines 9
1202 Geneva

At a glance

Legal form
Corporation
UID
CHE-235.919.086
Founded
2024 · 2 years
Last commercial register change
May 4, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    MT
    MindMaze Therapeutics Holding SA
    Geneva
    CB
    Campus Biotech Sàrl
    Geneva
    AT
    Addex Therapeutics Ltd
    Plan-Les-Ouates
    P&
    Procter & Gamble International Sàrl
    Petit-Lancy
    FS
    FONTELUNA SA
    Geneva
    MG
    MCI Group Holding SA
    Satigny
    MN
    MCI NEXT HOLDING SA
    Satigny
    RG
    Riverlake Group SA
    Geneva